Hypotensive effect of UDP on intraocular pressure in rabbits

European Journal of Pharmacology

Volumn 579, Issue 1-3, 2008, Pages 93-97

  Markovskaya, Anna ^a   Crooke, Almudena ^b   Guzmán Aranguez, Ana I ^b   Peral, Assumpta ^b   Ziganshin, Airat U ^a   Pintor, Jesús ^b  

^a KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Glaucoma; Intraocular pressure; IOP; P2Y6 receptors; UDP

Indexed keywords

CIBACRON BLUE F3GA; DORZOLAMIDE; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CILIARY MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLAUCOMA; HYPOTENSION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; CILIARY BODY; DOSE-RESPONSE RELATIONSHIP, DRUG; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; RABBITS; RECEPTORS, PURINERGIC P2; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

EID: 37549013803     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.040     Document Type: Article

References (25)

1. Abrams L.S., Vitale S., and Jampel H.D. Comparison of three tonometers for measuring intraocular pressure in rabbits. Investig. Ophthalmol. Vis. Sci. 37 (1996) 940-944
2. Burnstock G., and Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cyt. 240 (2004) 31-304
3. Clark A.F. Current trends in antiglaucoma therapy. Emerg. Drugs 4 (1999) 333-353
4. Communi D., Gonzalez N.S., Dethreux M., Brezillion S., Lannoy V., Parmentier M., and Boeynaems J.M. Identification of a novel human ADP receptor coupled to Gi. J. Biol. Chem. 276 (2001) 41479-41485
5. Crosson C.E. Adenosine receptor activation modulates intraocular pressure in rabbits. J. Pharmacol. Exp. Ther. 273 (1995) 320-326
6. Crosson C.E., and Gray T. Characterization of ocular hypertensión induced by adenosine agonists. Investig. Ophthalmol. Vis. Sci. 37 (1996) 1833-1839
7. Crosson C.E., Yates P.W., Bhat A.N., Mukhin Y.V., and Husain S. Evidence for multiple P2Y receptors in trabecular meshwork cells. J. Pharmacol. Exp. Ther. 309 (2004) 484-489
8. Davson H. The aqueous humour and the intraocular pressure. Physiology of the eye. 5th edition (1993), Pergamon Press, New York 34-95
9. Do C.W., and Civan M.M. Swelling activated chloride channels in aqueous humour formation: on the one side and the other. Acta Physiol. 187 (2006) 345-352
10. Erlinge D. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen. Pharmacol. 31 (1998) 1-8
11. Hollopeter G., Jantzen H.M., Vincent D., Li G., England L., Ramakrishnan V., Yang R.B., Nurden P., Nurden A., Julius D., and Conley P.B. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 409 (2001) 202-207
12. Nicholas R.A., Lazarowski E.R., Watt W.C., Li Q., Boyer J., and Harden T.K. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors. J. Auton. Pharm. 16 (1996) 319-323
13. North R.A., and Surprenant A. Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 563-580
14. Pintor J., and Peral A. Therapeutic potential of nucleotides in the eye. Drug Dev. Res. 52 (2001) 190-195
15. Pintor J., Peral A., Pelaez T., Martin S., and Hoyle C.H.V. Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure. J. Pharmacol. Exp. Ther. 304 (2003) 342-348
16. Pintor J., Pelaez T., and Peral A. Adenosine tetraphosphate, Ap4, a physiological regulator of intraocular pressure in normotensive rabbits. J. Pharmacol. Exp. Ther. 308 (2003) 468-473
17. Pintor J., Sanchez-Nogueiro J., Irazu M., Mediero A., Pelaez T., and Peral A. Immunolocalization of P2Y receptors in the rat eye. Pur. Signal. 1 (2004) 83-90
18. Robaye B., Boeynaems J.M., and Communi D. Low desensitization of the human P2Y6 receptor. Eur. J. Pharmacol. 329 (1997) 231-236
19. Sak K., and Webb T. A retrospective of recombinant P2Y receptros subtypes and their pharmacology. Arch. Biochem. Biophys. 397 (2002) 131-136
20. Soto D., Pintor J., Peral A., Gual A., and Gasull X. Effects of dinucleoside polyphosphates on trabecular meshwork cells and aqueous humor outflow facility. J. Pharmacol. Exp. Ther. 314 (2005) 1042-1051
21. von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 110 (2006) 415-432
22. Weinreb R.N., and Khaw P.T. Primary open-angle glaucoma. Lancet 363 (2004) 1711-1720
23. Weisman G.A., Wang M., Kong Q., Chorna N.E., Neary J.T., Sun G.Y., Gonzalez F.A., Seye C.I., and Erb L. Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Mol. Neurobiol. 31 (2005) 169-183
24. Yablonski M.E. Ocular hypertension treatment study. Arch. Ophthalmol. 122 (2004) 1088-1089
25. Zhang F.L., Luo L., Gustafson E., Palmer K., Qiao X., Fan X., Yang S., Laz T.M., Bayne M., and Monsma F. P2Y13: identification and characterisation of a novel Gai-coupled ADP receptor from human and mouse. J. Pharmacol. Exp. Ther. 301 (2002) 705-713